chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Feeling pretty poorly since receiving his second Covid vaccine on 20-Feb-2021, which was similar to how he felt after his first  dose; This spontaneous case was reported by a physician and describes the occurrence of FEELING ABNORMAL (Feeling pretty poorly since receiving his second Covid vaccine on 20-Feb-2021, which was similar to how he felt after his first  dose) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Edema of lower extremities, Basal squamous cell carcinoma in 2017, Rash in August 2020, Nausea in August 2020, Fever (Pyrexia) in August 2020 and Barrett's esophagus. Concurrent medical conditions included Mesothelioma since 28-Sep-2017, Dyspnea since 2017, Paroxysmal atrial fibrillation since August 2020, Gastroesophageal reflux disease, Hypertension, Obesity, Hypokalemia since 04-Sep-2020, Vomiting since 2017, Obstructive sleep apnea syndrome since 2016, Fatigue since 2016, Anxiety, Constipation since 10-Aug-2020 and Oedema peripheral since 2019. Concomitant products included LORAZEPAM from 24-Oct-2017 to an unknown date, LOSARTAN from 29-Sep-2017 to an unknown date, ONDANSETRON from 28-Sep-2017 to an unknown date, POTASSIUM CHLORIDE, PROCHLORPERAZINE from 11-Jun-2019 to an unknown date, WARFARIN from 30-Jan-2016 to an unknown date, LIDOCAINE, PRILOCAINE (LIDOCAINE AND PRILOCAINE), VANCOMYCIN from 09-Dec-2020 to an unknown date, POTASSIUM PHOSPHATE MONOBASIC, SODIUM PHOSPHATE DIBASIC, SODIUM PHOSPHATE MONOBASIC (ANHYDROUS) (K-PHOS NEUTRAL) from 09-Dec-2020 to an unknown date, OXYCODONE from 28-Jan-2021 to an unknown date, APIXABAN from 17-Feb-2021 to an unknown date, DILTIAZEM from 20-Feb-2016 to an unknown date and FLECAINIDE from 11-Mar-2016 to an unknown date for an unknown indication.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On an unknown date, the patient experienced FEELING ABNORMAL (Feeling pretty poorly since receiving his second Covid vaccine on 20-Feb-2021, which was similar to how he felt after his first  dose). At the time of the report, FEELING ABNORMAL (Feeling pretty poorly since receiving his second Covid vaccine on 20-Feb-2021, which was similar to how he felt after his first  dose) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment details were provided.  It was reported that  patient had feeling pretty poorly since receiving his second Covid vaccine on 20-Feb-2021, which was similar to how patient felt after first dose and after anticancer treatment.
Tachycardia, fatigue and 'brain fog' Noticed in October 2022 and started to wane in May/June 2023. Started on Cardizem for tachycardia in March 2023.
Arm went completely numb at 3:00 and stayed that way for 24 hours. Feeling came back but I do not have strength or movement.
I was starting to get headaches, but I did not associate it my blood pressure. I decided to take my blood pressure and it was 185/105. Although my blood pressure is not necessarily always normal that is very high for me. I called and made an appointment to see my doctor. She and I worked with different medications to get a combination of medications that work together to get my blood pressure under control.
Sore arm; Felt a little tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and FATIGUE (Felt a little tired) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm) and FATIGUE (Felt a little tired). At the time of the report, PAIN IN EXTREMITY (Sore arm) and FATIGUE (Felt a little tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.  No treatment medications reported.   This case was linked to MOD-2021-372881, MOD-2021-372950 (Patient Link).
Large red and purple oval around shot hole of the shot. This grew seen throughout the day and spread larger. Then I tried BENADRYL and ice on and off. Three hours past, it did nothing. Have her a warm shower. This made it look much worse. The next two days after that she couldn't keep food or drinks down with extreme vomiting. Now that it's Monday, I've tried her pediatrician. Phones weren't responding so I walked in with her. They looked at her from across a dark hallway. No examining. They said she has a stomach bug on top of the reasons from the shot. They also went against what their own paperwork says by saying that there bailed do not cause vomiting or fevers.
SEVERE headache within 20 minutes of shot.  Followed by nausea, vomiting and dizziness.  At this point has been continual for 4 days.
STROKE; This spontaneous report received from a consumer via a company representative via social media concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, 1 total start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced stroke. It was reported that, "My daughter had a stroke". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of stroke was not reported. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20221143337.; Sender's Comments: 20221146283- stroke. The event has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event. Therefore, the WHO Causality is considered indeterminate. The company causality is considered unassessable.
Adacel,Typhim Vi,Tubersol(open) that were administered after the excursion, No AE; Initial information received on 21-May-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a 17 years old female patient who received vaccines TYPHOID VI POLYSACCHARIDE VACCINE [TYPHIM VI], DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] (lot number, expiry date, dose, route and site of administration were not reported for both) and TUBERCULIN TEST [TUBERSOL](lot - C5568AA, 05-Apr-2021 via intradermal route in left forearm) after the excursion, on 20-May-2019.  The other products that were exposed were Acthib, Ipol, Imogam, Imovax and Tenivac. All open products were discarded.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was an actual medication error case due to incorrect product storage.  It was reported as the excursion happened from 18May 2019 to 20 May 2019.1 degrees C was the lowest temp reached. The total amount of time out of range was 24 hours. Tubersol dose that was stored outside of range. The Tubersol vial used was at 1 C for 24 hrs.  No adverse event specifically reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Information on the batch number was requested for TYPHIM VI and ADACEL.  List of documents held by sender: none.
Information has been received from a Doctor of Pharmacy concerning a patient who on 09-SEP-2009 was vaccinated with a dose of ZOSTAVAX (Merck). The patient experienced "temporal arteritis and polyneuralgia" after receiving ZOSTAVAX (Merck). The patient's outcome was unknown. It was unknown if the patient sought medical attention. Follow up information has been received from the pharmacist concerning a 66 year old female delivery driver with no illness at the time of the vaccination, no chronic disease and milk allergy no on 16-SEP-2009 (Previously reported as of 09-SEP-2009) was vaccinated subcutaneously with a first dose of ZOSTAVAX (Merck) (lot# 663880/0791Y) into right arm. Approximately 2-3 weeks after receiving vaccine, on approximately 07-OCT-2009, the patient began having pain in arms, legs and hips. The patient also began having severe headaches and started having ear infections and hearing loss. The patient was treated with multiple antibiotics and steroids which helped with muscle pain temporarily. On 10-DEC-2009 the patient was prescribed IBUPROFEN 800 mg which slightly helped with pain in muscles. Family physician recently sent the patient to a vascular surgeon. The vascular surgeon took blood levels of sedimentation rate of 96 mm/hour. At the time of the report, the patient was undergoing temporal biopsy in the next week. So far the patient had been diagnosed with polyneuralgia and being tested for temporal arteritis. At the time of the report, the patient had not recovered. Upon internal review, hearing loss was determined to be an other important medical event. Additional information has been requested.
Started with extreme fatigue on 9/16, worse than I have had before. Went to bed as soon as I got home from work and slept all night. Woke up on 9/17 with nausea and diarrhea. Today, I still have some nausea and diarrhea.
Had a really swollen, sore arm - and under arm pits it was really swollen too. I toughed it out for a couple of weeks. I called the clinic when it was still sore. I was not able to lift weights when I exercise - I was dropping them. I called the clinic and talked to a nurse. On June 22nd, around 1:00 or 2:00 - my whole left side went numb. I couldn't speak. Left side of face was drooping. I had blurred vision. But then it got a little better within an hour or two ( I could communicate) and I called the clinic said to come in on 23rd - doctor thought I was still having a stroke due to symptoms observed. I have an optometrist is going to check my eyes. I am going to get a physical done next month (August 9th) at the clinic. I work out and tried to do some neck exercises - and dr noticed a past injury of  left side of face -that happened 45 years ago - on the CT. Dr wonders if it's related to that . I decided to do some neck exercises on Monday and yesterday I was bedridden after doing those exercises - lymph nodes swelled up. I still have some blurry vision; my face is still drooping but just a little bit. I do jumble my words.
shingles; Information has been received from a lawyer regarding a case in litigation, referring a patient of unknown age and gender. Information regarding medical history, concurrent conditions and concomitant medication was no provided. On an unknown date in 2016, the patient was vaccinated with zoster vaccine live (ZOSTAVAX), (route, lot number, expiration date, strength and anatomical site of vaccination were unknown) for prophylaxis. On an unknown date, the patient experienced herpes zoster (shingles), patient received an unspecified treatment and was hospitalized on an unknown date. As a direct and proximate result of use of the vaccine, patient had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; other losses and damages; would continue to suffer such losses, and damages in the future. The outcome of herpes zoster was unknown. The reporter considered the event to be related to Zoster Vaccine Live (ZOSTAVAX).
Diabetes control was an A1c of 7% before vaccination (no medication use). Within a few weeks of vaccination, an A1c was checked and level of control was all the way up to 14.5%; This is a spontaneous report from a contactable physician. A 63-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration on 03Mar2021 (at the age of 63-years-old) and also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration on 24Mar2021 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes which was under control in which glycated hemoglobin (A1C) was 7% (unknown units) before vaccination (no medication use). Concomitant medications were not reported. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had injection 1 and injection 2 in Mar2021. On 19May2021, within a few weeks of vaccination, an "A1c" was checked and the level of control was all the way up to 14.5% (unknown units). The events did not result in a visit to the doctors or other healthcare professional office/clinic, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the event and included treatment with diabetes medications (unspecified). On 19May2021, the patient underwent glycated hemoglobin (HbA1C) test and the result was 14.5 % (unknown units). Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the event within a few weeks of vaccination, an "A1C" was checked and the level of control was all the way up to 14.5% was resolved with sequelae on an unknown date in 2021. The patient also received the third dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 30145 BA) via intramuscular route of administration on 11Oct2021 (at the age of 64-years-old) as a single dose for COVID-19 immunisation.  The lot numbers for BNT162b2 were not provided and will be requested during follow-up.
Patient states that she has experienced swelling of the left side of face and very lumpy. That her eyes are almost swollen shut.
patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication reported.  It was reported that there had been no power outages that would have impacted the Moderna vaccine. However, the Healthcare professional reiterates that because facility was unable to download the digital data logger, they would need to treat this issue as a temperature excursion. The data logger was unable to download for the months of Dec-2021, Jan-2022, and Feb-2022. They were filling out a temperature excursion assessment at that time. It was reported that no adverse reactions were reported by any patients.  No treatment medication reported.
Patient reported dizziness, muffled hearing, left ear pain, left jaw pain, feeling hot, sweating, feeling like the needle hit bone.  The symptoms had cleared up after around 5 minutes.
Patient received a total of 4 doses of BEXSERO. 1st dose- 7/1/2016 2nd dose- 7/11/17 3rd dose- 8/15/17 4th dose - 11/2/18.
Chills, body ache, bones ache, soreness in hand, low blood pressure, weakness, dry mouth, dizziness, sweating, fatigue, sleepiness, drowsiness.
Patient developed localized swelling, redness and pain at injection site followed by throat swelling and respiratory distress.
Arm was very sore soon after receiving shot.  After falling asleep, woke up at 1am with fever of 100.5.  Had chills and sweats.  Tossed and turned for 4-5 hours, fell back asleep.  Woke up and spent day taking it easy, not working, just resting and being lazy.  Went to sleep and woke up again in the middle of the night with a fever of 99.5.  Tossed and turned for a couple hours, fell back asleep.  Woke up and felt fine, except for sore arm for an additional few days.
SORE FEELING AT INJECTION SITE; This spontaneous report received from a consumer via a company representative through social media concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced sore feeling at injection site. The action taken with covid-19 vaccine  was not applicable. The outcome of sore feeling at injection site was not reported. This report was non-serious. This case, from the same reporter is linked to .
Extreme flushing. Extreme headache. Extreme neck pain. Extreme back pain-traveling down spine. EKG and monitoring of vital signs; observation.
Chest tightness in the morning after with shortness of breath. Mild cough and neck spasms. Patient received prednisolone
Difficulty walking; pain in both knees; Weakness in legs; Lower back pain; Fatigue; Headache; Sorearm; This case was reported by a consumer via call center representative and described the occurrence of fatigue in a 74-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included arthritis and acute back pain.   In April 2019, the patient received the 1st dose of Shingrix (intramuscular). In April 2019, 14 days after receiving Shingrix, the patient experienced walking difficulty, knee pain, lower extremities weakness of and back pain aggravated. On an unknown date, the patient experienced fatigue, headache and pain in arm. On an unknown date, the outcome of the fatigue, headache and pain in arm were recovered/resolved and the outcome of the walking difficulty, knee pain, lower extremities weakness of and back pain aggravated were unknown.   It was unknown if the reporter considered the fatigue, headache, pain in arm, walking difficulty, knee pain, lower extremities weakness of and back pain aggravated to be related to Shingrix.  Additional details were provided as follows: The reporter was the patient herself.  About 3 weeks ago (of the date of reporting), the patient received dose 1 of Shingrix, in the left arm. About 2 weeks post vaccination, the patient started experiencing hard time walking, pain in both knees and more dominant in the right knee, weakness in legs and more lower back pain than usual. The patient experienced sore arm and headache which lasted for 4 days, and fatigue which lasted for 5 days.  The patient referred to health care professional.  The patient consented to follow up.  No further details were provided.  The reporter also reported adverse event for her husband, refer case US2019080737.
I received the ZOSTAVAX vaccine on 9/8/17 and developed symptoms of Shingles on 9/12. Doctor verified diagnosis on 9/14/17.
pt recvd vax;mom got up & noted pt was afebrile & shaking;not jerking;became limp;no fever;meds given since bedtime;never jerked turned blue or became completely unresponsive;to er,dx w/ otitis med;T 102;
A report was received from a health professional on 10/21/02, concerning 12 adult vaccinee's who were inadvertently administered frozen Fluvirin vaccine on 10/18/02. They will be re-vaccinated in approximately 4 weeks. The vaccinee's have not experienced any adverse effects. The reporter has assessed the relationship of the vaccine to the event as unclassifiable.
Pt reported itching in throat and tingling on left side of face. tightness in face started.  BP: 134/77, HR 89. O2- 98%
Severe hives.  Went to Urgent Care.  Prescribed Benadryl, Zyrtec, Prednisone.
The injection site swollen about 2 1/2 inches in diameter (redness, hardness and itchy). As of 3/18/21 it is still a bit red, but has went down significantly.  Severely swollen lymph nodes in right arm pit. I did not notice any swelling until Friday, 3/12/21 around 4:30 pm and by Saturday morning the swelling had spread tremendously. As of 3/18/21, the swelling has gone down significantly.   Since there was no place to report this, I wanted to let you know that I tested positive for COVID19 on October 9, 2020
Pt injected with incorrect covid vaccine for 2nd dose.  Moderna expected to be given, pfizer vaccine given instead.
1st dose in 2019, wants to get 2nd dose; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in August 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were reported as follows: The age at vaccination was not applicable for this report. Registered pharmacist reported that a patient wanted to get 2nd dose of Shingrix and did not receive 2nd dose till time of reporting which led to incomplete course of vaccination.  The reporter asked what would be the best practices, how to proceed with schedule. The reporter provided limited information regarding patient. Lot number and expiration date were not available. The reporter did not consent to follow-up.
Thigh swollen, red, slightly indurated and slightly warm 5x4cm by shot site.
About 30 minutes after leaving the site I experienced palpitations. And sharp pain in left side.